Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 361 to 365 of 365 results for heart failure

  1. NICE draft guidance recommends new treatment for chronic heart failure

    Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE.

  2. People at risk of severe COVID-19 to have access to antiviral Paxlovid

    A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be eligible for Paxlovid if they test positive.

  3. First treatment to target heart condition set to benefit

    NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.

  4. NICE recommends life-changing gene therapy for children with ultra-rare genetic disorder

    The first and currently only gene therapy for children with an ultra-rare genetic disorder has been recommended by NICE.

  5. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)

    Evidence-based recommendations on extracorporeal membrane oxygenation for severe acute respiratory failure in adults. This involves using a tube to carry blood from the right side of the heart and then pump it through an artificial lung where it picks up oxygen.